Daiwa Securities Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-126
| Closed | -$13K | – | 1366 |
|
|
2023
Q2 | $13K | Hold |
126
| – | – | ﹤0.01% | 1122 |
|
|
2023
Q1 | $11K | Buy |
126
+18
| +17% | +$1.57K | ﹤0.01% | 1101 |
|
|
2022
Q4 | $4K | Hold |
108
| – | – | ﹤0.01% | 1170 |
|
|
2022
Q3 | $3K | Hold |
108
| – | – | ﹤0.01% | 1204 |
|
|
2022
Q2 | $3K | Hold |
108
| – | – | ﹤0.01% | 1205 |
|
|
2022
Q1 | $4K | Hold |
108
| – | – | ﹤0.01% | 1198 |
|
|
2021
Q4 | $3K | Hold |
108
| – | – | ﹤0.01% | 1255 |
|
|
2021
Q3 | $11K | Buy |
108
+46
| +74% | +$4.69K | ﹤0.01% | 1129 |
|
|
2021
Q2 | $9K | Hold |
62
| – | – | ﹤0.01% | 1044 |
|
|
2021
Q1 | $6K | Buy |
62
+8
| +15% | +$774 | ﹤0.01% | 1072 |
|
|
2020
Q4 | $7K | Sell |
54
-106
| -66% | -$13.7K | ﹤0.01% | 1036 |
|
|
2020
Q3 | $16K | Buy |
160
+7
| +5% | +$700 | ﹤0.01% | 1004 |
|
|
2020
Q2 | $22K | Hold |
153
| – | – | ﹤0.01% | 1007 |
|
|
2020
Q1 | $22K | Hold |
153
| – | – | ﹤0.01% | 994 |
|
|
2019
Q4 | $31K | Hold |
153
| – | – | ﹤0.01% | 980 |
|
|
2019
Q3 | $12K | Hold |
153
| – | – | ﹤0.01% | 1015 |
|
|
2019
Q2 | $14K | Hold |
153
| – | – | ﹤0.01% | 1024 |
|
|
2019
Q1 | $13K | Buy |
153
+43
| +39% | +$3.65K | ﹤0.01% | 1008 |
|
|
2018
Q4 | $6K | Hold |
110
| – | – | ﹤0.01% | 1036 |
|
|
2018
Q3 | $9K | Hold |
110
| – | – | ﹤0.01% | 1037 |
|
|
2018
Q2 | $4K | Hold |
110
| – | – | ﹤0.01% | 1098 |
|
|
2018
Q1 | $2K | Buy |
+110
| New | +$2K | ﹤0.01% | 1125 |
|
|
2017
Q2 | – | Sell |
-36,611
| Closed | -$829K | – | 1005 |
|
|
2017
Q1 | $829K | Buy |
+36,611
| New | +$829K | 0.01% | 482 |
|